{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:52:29Z","timestamp":1761519149362,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["015761,015764"],"award-info":[{"award-number":["015761,015764"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA77202"],"award-info":[{"award-number":["CA77202"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000142","name":"Avon Foundation for Women","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000142","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10549-016-3761-8","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T01:55:14Z","timestamp":1458698114000},"page":"343-349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27"],"prefix":"10.1007","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9522-0211","authenticated-orcid":false,"given":"Judith-Anne W.","family":"Chapman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois E.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James N.","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyman B.","family":"Muss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen I.","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen A.","family":"Gelmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,23]]},"reference":[{"key":"3761_CR1","unstructured":"Cancer survival statistics for common cancers. Cancer Research UK \n                    http:\/\/www.cancerresearchuk.org\/cancer\n                    \n                   info\/cancerstats\/survival\/common-cancers\/"},{"key":"3761_CR2","unstructured":"Cancer advances in focus. Breast cancer. National Cancer Institute at the National Institutes of Health. \n                    http:\/\/www.cancer.gov\/cancertopics\/factsheet\/cancer-advances-in-focus\/breast"},{"key":"3761_CR3","unstructured":"Breast cancer facts and figures\u00a02011\u20132012. American Cancer Society \n                    http:\/\/www.cancer.org\/acs\/groups\/content\/@epidemiologysurveilance\/documents\/document\/acspc-030975.pdf\n                    \n                  : 2,9"},{"key":"3761_CR4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2001.19.4.980","volume":"19","author":"PM Ravdin","year":"2001","unstructured":"Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N, Parker HL (2001) Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19:980\u2013991","journal-title":"J Clin Oncol"},{"key":"3761_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF02303502","volume":"5","author":"EB Fish","year":"1998","unstructured":"Fish EB, Chapman JW, Link MA (1998) Competing causes of death for primary breast cancer. Ann Surg Oncol 5:368\u2013375","journal-title":"Ann Surg Oncol"},{"key":"3761_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/jnci\/djn014","volume":"100","author":"JW Chapman","year":"2008","unstructured":"Chapman JW, Meng D, Shepherd L, Parulekar W, Ingle JN, Muss HB, Palmer M, Yu C, Goss PE (2008) Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst 100:252\u2013260. doi:\n                    10.1093\/jnci\/djn014","journal-title":"J Natl Cancer Inst"},{"key":"3761_CR7","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/S0140-6736(08)60933-2","volume":"371","author":"J Cuzick","year":"2008","unstructured":"Cuzick J (2008) Primary endpoints for randomized trials of cancer therapy. Lancet Oncol 371:2156\u20132158","journal-title":"Lancet Oncol"},{"key":"3761_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2307\/2347158","volume":"27","author":"SW Lagakos","year":"1978","unstructured":"Lagakos SW (1978) A covariate model for partially censored data subject to competing causes of failure. Appl Stat 27:235\u2013241. doi:\n                    10.2307\/2347158","journal-title":"Appl Stat"},{"key":"3761_CR9","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1200\/JCO.2012.44.7805","volume":"31","author":"PE Goss","year":"2013","unstructured":"Goss PE, Ingle JN, Pritchard KI, Sledge GW, Budd GT, Rabaglio M, Ansari RH, Johnson DB, Tozer R, D\u2019Souza DP, Chalchal H, Spadafora S, Stearns V, Perez EA, Liedke PE, Lang I, Elliott C, Gelmon KA, Chapman JA, Shepherd LE (2013) Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27\u2014a randomized controlled phase III trial. J Clin Oncol 31:1398\u20131404. doi:\n                    10.1200\/JCO.2012.44.7805","journal-title":"J Clin Oncol"},{"key":"3761_CR10","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.5306\/wjco.v5.i5.1088","volume":"5","author":"JW Chapman","year":"2014","unstructured":"Chapman JW, Pritchard KI, Goss PE, James NI, Hyman BM, Susan FD, Ted AV, Findlay B, Gelmon KA, Wilson CF, Shepherd LE, Pollak MN (2014) Competing risks of death in younger and older postmenopausal breast cancer patients. World J Clin Oncol 5:1088\u20131096. doi:\n                    10.5306\/wjco.v5.i5.1088","journal-title":"World J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3761-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3761-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3761-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3761-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:13:00Z","timestamp":1589721180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3761-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,23]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3761"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3761-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2016,3,23]]},"assertion":[{"value":"11 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}